DermTech, Inc.

DermTech, Inc., the precision dermatology company that trades under the legacy SPAC ticker CNAC, filed an 8-K current report with the SEC on June 18, 2024, bearing accession number 0001651944-24-000060. DermTech reached the public markets through a business combination with Constellation Alpha Capital Corp, a healthcare-focused blank-check vehicle that completed its IPO in 2018 with Constellation Alpha Capital LLC serving as sponsor. The combined company operates in the precision diagnostics segment of the healthcare sector, commercializing non-invasive genomic tests for skin conditions. The June 2024 filing reflects the company's ongoing post-merger public reporting obligations. Visit SpacDesk and sign up for full data, filings history, and deal analytics on CNAC and hundreds of other SPAC transactions.